158 related articles for article (PubMed ID: 32202903)
1. Evaluation of synuclein-γ levels by novel monoclonal antibody in saliva and cancer tissues from oral squamous cell carcinoma patients.
Wang K; Shen Y; Xu J; Li Z; Liu Y; Yu C; Peng L; Zheng J; Zeng Y
Neoplasma; 2020 May; 67(3):707-713. PubMed ID: 32202903
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Synuclein-
Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
[TBL] [Abstract][Full Text] [Related]
3. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma.
Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS
J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712
[TBL] [Abstract][Full Text] [Related]
4. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
5. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
Liu C; Guo J; Qu L; Bing D; Meng L; Wu J; Shou C
Cancer Lett; 2008 Sep; 269(1):148-58. PubMed ID: 18586385
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
7. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA; Shaker OG
Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
[TBL] [Abstract][Full Text] [Related]
8. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
[TBL] [Abstract][Full Text] [Related]
9. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study.
Balan JJ; Rao RS; Premalatha BR; Patil S
J Contemp Dent Pract; 2012 Sep; 13(5):671-5. PubMed ID: 23250173
[TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.
Cirak Y; Furuncuoglu Y; Yapicier O; Alici S; Argon A
Int J Clin Exp Pathol; 2015; 8(5):5345-53. PubMed ID: 26191236
[TBL] [Abstract][Full Text] [Related]
11. Expression of SNCG, MAP2, SDF-1 and CXCR4 in gastric adenocarcinoma and their clinical significance.
Zheng S; Shi L; Zhang Y; He T
Int J Clin Exp Pathol; 2014; 7(10):6606-15. PubMed ID: 25400739
[TBL] [Abstract][Full Text] [Related]
12. Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma.
Chaiyarit P; Utrawichian A; Leelayuwat C; Vatanasapt P; Chanchareonsook N; Samson MH; Giraud AS
Clin Oral Investig; 2012 Dec; 16(6):1549-56. PubMed ID: 22205269
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
Jaafari-Ashkavandi Z; Aslani E
Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.
Min L; Zhang C; Ma R; Li X; Yuan H; Li Y; Chen R; Liu C; Guo J; Qu L; Shou C
BMC Cancer; 2016 Sep; 16(1):717. PubMed ID: 27595752
[TBL] [Abstract][Full Text] [Related]
15. Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission.
Cheng YS; Rees T; Jordan L; Oxford L; O'Brien J; Chen HS; Wong D
Oral Oncol; 2011 Dec; 47(12):1122-6. PubMed ID: 21868280
[TBL] [Abstract][Full Text] [Related]
16. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
17. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.
Ko HH; Peng HH; Cheng SJ; Kuo MY
Head Neck; 2018 Dec; 40(12):2642-2647. PubMed ID: 30430672
[TBL] [Abstract][Full Text] [Related]
18. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma.
Ajona D; Pajares MJ; Chiara MD; Rodrigo JP; Jantus-Lewintre E; Camps C; Suarez C; Bagán JV; Montuenga LM; Pio R
Oral Dis; 2015 Oct; 21(7):899-904. PubMed ID: 26258989
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
20. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
Metgud R; Bajaj S
Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]